Intermediate monocytes and TEMs additionally revealed significantly enhanced expression levels of CD16 in cancer patients compared to healthy volunteers (Fig. 4), whereas TIE2 expression levels of TEMs were not altered in disease. The gene discussed is TEK; the disease is cancer.